SCHEMBL25604202

SCHEMBL25604202

Cc1ccc(C(=O)N[C@H]2CC[C@@H](N(C)c3cccc4nc(C(F)(F)F)cn34)CC2)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ MCHR1 Q99705 5/20 0.41
▸ ADRA2A P08913 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ HRH1 P35367 2/20 0.41
▸ HTR2B P41595 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HDAC4 P56524 1/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ MAPK13 O15264 1/20 0.38
▸ HPGDS O60760 3/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ PHGDH O43175 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25605107 0.93 MCHR1 (0.43) NPC1RAB9AMCHR1ADRA2AHRH1
SCHEMBL25606159 0.93 ADRA2A (0.45) NPC1RAB9AMCHR1ADRA2AHPGD
SCHEMBL25604129 0.92 MCHR1 (0.42) NPC1RAB9AMCHR1ADRA2AHRH1
SCHEMBL25604145 0.92 NPC1 (0.41) NPC1RAB9AMCHR1ADRA2AHRH1
SCHEMBL25605122 0.92 NPC1 (0.41) NPC1RAB9AMCHR1ADRA2AHRH1
SCHEMBL25604169 0.91 MCHR1 (0.47) NPC1RAB9AMCHR1ADRA2AHRH1
SCHEMBL25604207 0.91 NPC1 (0.39) NPC1RAB9AMCHR1ADRA2AHRH1
SCHEMBL25605157 0.91 NPC1 (0.40) NPC1RAB9AMCHR1ADRA2AHRH1
SCHEMBL25602086 0.90 KMT2A (0.42) MCHR1CYP2C19SMN1; SMN2ALDH1A1LMNA
SCHEMBL25604204 0.90 MEN1 (0.38) NPC1RAB9AMCHR1ADRA2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303567-A1 MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS ESCIENT PHARMACEUTICALS INC (US) 2023-09-28 — — US disclosed
US-11667636-B2 Modulators of Mas-related G-protein receptor X2 and related products and methods ESCIENT PHARMACEUTICALS, INC. (US) 2023-06-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667636-B2 Modulators of Mas-related G-protein receptor X2 and related products and methods MRGPRX2, MRGPRX1, MRGPRX4 NPC1 2003/4885RAB9A 478/4885MCHR1 35/4885
US-20230303567-A1 MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS MRGPRX2, MRGPRX1, MRGPRX4 NPC1 2003/4885RAB9A 478/4885MCHR1 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback